Citation: Sjm. Neele et al., SALINE INFUSION SONOHYSTEROGRAPHY IS A GOOD APPROACH FOR ADDITIONAL ASSESSMENT OF THE ENDOMETRIUM, European journal of cancer, 34, 1998, pp. 35-36
Authors:
VANITTERSUM FJ
VANBAAL WM
KENEMANS P
MIJATOVIC V
DONKER AJM
VANDERMOOREN MJ
STEHOUWER CDA
Citation: Fj. Vanittersum et al., AMBULATORY NOT OFFICE BLOOD PRESSURES DECLINE DURING HORMONE REPLACEMENT THERAPY IN HEALTHY POSTMENOPAUSAL WOMEN, American journal of hypertension, 11(10), 1998, pp. 1147-1152
Authors:
VANDERMOOREN MJ
MIJATOVIC V
VANBAAL WM
STEHOUWER CDA
Citation: Mj. Vandermooren et al., HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN WITH SPECIFIC RISK-FACTORS FOR CORONARY-ARTERY DISEASE, Maturitas, 30(1), 1998, pp. 27-36
Authors:
MIJATOVIC V
KENEMANS P
JAKOBS C
VANBAAL MV
PETERSMULLER ER
VANDERMOOREN MJ
Citation: V. Mijatovic et al., A RANDOMIZED CONTROLLED-STUDY OF THE EFFECTS OF 17BETA-ESTRADIOL-DYDROGESTERONE ON PLASMA HOMOCYSTEINE IN POSTMENOPAUSAL WOMEN, Obstetrics and gynecology, 91(3), 1998, pp. 432-436
Authors:
MIJATOVIC V
KENEMANS P
NETELENBOS C
JAKOBS C
POPPSNIJDERS C
PETERSMULLER ER
VANDERMOOREN MJ
Citation: V. Mijatovic et al., POSTMENOPAUSAL ORAL 17-BETA-ESTRADIOL CONTINUOUSLY COMBINED WITH DYDROGESTERONE REDUCES FASTING SERUM HOMOCYSTEINE LEVELS, Fertility and sterility, 69(5), 1998, pp. 876-882
Citation: Tpj. Mulder et al., EFFECTS OF HORMONE REPLACEMENT THERAPY ON PLASMA GLUTATHIONE-S-TRANSFERASE A1-1 CONCENTRATIONS IN HEALTHY POSTMENOPAUSAL WOMEN, Clinical chemistry, 44(3), 1998, pp. 666-667
Citation: Np. Koper et al., SERUM CA-125 CONCENTRATIONS IN WOMEN OF DIFFERENT AGES, HORMONAL STATUSES, OR CLINICAL CONDITIONS, International journal of gynecological cancer, 7(5), 1997, pp. 405-411
Authors:
PINES A
MIJATOVIC V
VANDERMOOREN MJ
KENEMANS P
Citation: A. Pines et al., HORMONE REPLACEMENT THERAPY AND CARDIOPROTECTION - BASIC CONCEPTS ANDCLINICAL CONSIDERATIONS, European journal of obstetrics, gynecology, and reproductive biology, 71(2), 1997, pp. 193-197
Authors:
MIJATOVIC V
KENEMANS P
NETELENBOS JC
PETERSMULLER ERA
VANKAMP GJ
VOETBERG GA
VANDEWEIJER PHM
VANDERMOOREN MJ
Citation: V. Mijatovic et al., ORAL 17-BETA-ESTRADIOL CONTINUOUSLY COMBINED WITH DYDROGESTERONE LOWERS SERUM LIPOPROTEIN(A) CONCENTRATIONS IN HEALTHY POSTMENOPAUSAL WOMEN, The Journal of clinical endocrinology and metabolism, 82(11), 1997, pp. 3543-3547
Citation: Mj. Vandermooren et al., THE EFFECT OF SEQUENTIAL 3-MONTHLY HORMONE REPLACEMENT THERAPY ON SEVERAL CARDIOVASCULAR RISK ESTIMATORS IN POSTMENOPAUSAL WOMEN, Fertility and sterility, 67(1), 1997, pp. 67-73
Authors:
ALAZZAWI F
VANDERMOOREN MJ
ROLLAND R
HIRVONEN E
BRINCAT M
BURGGRAAFF J
KELLER P
HEIKKINEN J
BACKAS N
FACCINI V
OMODEI U
VONSCHOULTZ B
ABEL B
RAAS P
SCHONBERG L
SCHOLZ H
SUERBURG D
SCHOPP R
LAVEISSIERE M
QUEREUX C
CHURLET A
BERNARD P
FRYDMAN R
Citation: F. Alazzawi et al., A RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF A NEW 17-BETA-ESTRADIOL TRANSDERMAL MATRIX PATCH WITH ESTRADERM TTS-50 IN HYSTERECTROMISED POSTMENOPAUSAL WOMEN, British journal of clinical practice, 51(1), 1997, pp. 20
Citation: Jag. Leuven et al., THE EFFECT OF MEDROGESTONE ON PLASMA-LIPIDS AND LIPOPROTEINS IN POSTMENOPAUSAL WOMEN USING CONJUGATED ESTROGENS - AN OPEN RANDOMIZED COMPARATIVE-STUDY, Fertility and sterility, 64(3), 1995, pp. 525-531
Authors:
VANDERMOOREN MJ
HANSELAAR AGJM
BORM GF
ROLLAND R
Citation: Mj. Vandermooren et al., CHANGES IN THE WITHDRAWAL BLEEDING PATTERN AND ENDOMETRIAL HISTOLOGY DURING 17-BETA-ESTRADIOL DYDROGESTERONE THERAPY IN POSTMENOPAUSAL WOMEN - A 2-YEAR PROSPECTIVE-STUDY, Maturitas, 20(2-3), 1994, pp. 175-180
Citation: Mj. Vandermooren et al., EFFECT OF CONJUGATED ESTROGENS WITH AND WITHOUT MEDROGESTONE - A PROSPECTIVE-STUDY, Maturitas, 19(1), 1994, pp. 33-42
Citation: Mj. Vandermooren et al., CHANGES IN THE LOW-DENSITY-LIPOPROTEIN PROFILE DURING 17-BETA-ESTRADIOL DYDROGESTERONE THERAPY IN POSTMENOPAUSAL WOMEN, Metabolism, clinical and experimental, 43(7), 1994, pp. 799-802
Authors:
VANDERMOOREN MJ
WOUTERS MGAJ
BLOM HJ
SCHELLEKENS LA
ESKES TKAB
ROLLAND R
Citation: Mj. Vandermooren et al., HORMONE REPLACEMENT THERAPY MAY REDUCE HIGH SERUM HOMOCYSTEINE IN POSTMENOPAUSAL WOMEN, European journal of clinical investigation, 24(11), 1994, pp. 733-736
Authors:
VANDERMOOREN MJ
DEMACKER PNM
THOMAS CMG
BORM GF
ROLLAND R
Citation: Mj. Vandermooren et al., A 2-YEAR STUDY ON THE BENEFICIAL-EFFECTS OF 17-BETA-ESTRADIOL-DYDROGESTERONE THERAPY ON SERUM-LIPOPROTEINS AND LP(A) IN POSTMENOPAUSAL WOMEN - NO ADDITIONAL UNFAVORABLE EFFECTS OF DYDROGESTERONE, European journal of obstetrics, gynecology, and reproductive biology, 52(2), 1993, pp. 117-123
Authors:
SCHIJF CPT
VANDERMOOREN MJ
DOESBURG WH
THOMAS CMG
ROLLAND R
Citation: Cpt. Schijf et al., DIFFERENCES IN SERUM-LIPIDS, LIPOPROTEINS, SEX-HORMONE BINDING GLOBULIN AND TESTOSTERONE BETWEEN THE FOLLICULAR AND THE LUTEAL-PHASE OF THEMENSTRUAL-CYCLE, Acta endocrinologica, 129(2), 1993, pp. 130-133